A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show ...

In a first-in-human phase 1/2a clinical trial, researchers used adult stem cells to help restore vision in people with age-related macular degeneration. In the United States, age-related macular degen ...

The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety ...

Aalto University scientists have created a laser-based treatment that uses gentle heat to stop the progression of dry macular ...

A new approach pioneered by Aalto University scientists uses controlled warmth to trigger self-repair within retinal cells ...

Age-related macular degeneration (AMD) is one of the leading causes of vision loss among adults over 65. This condition ...

Cirrus’ lead program is a novel AAV gene therapy designed to restore IRAK-M, a central regulator of the eye’s immune homeostasis, so as to prevent AMD progression and preserve central vision IRAK-M ...

ANNX advances tanruprubart for Guillain-Barré syndrome, with an EMA filing planned for January 2026 and ongoing FDA ...

DUBLIN--(BUSINESS WIRE)--The "Dry Age-Related Macular Degeneration - Epidemiology Forecast - 2034" report has been added to ResearchAndMarkets.com's offering. The "Dry AMD -Epidemiology - 2034" report ...

Please provide your email address to receive an email when new articles are posted on . Female smokers had a greater visual acuity decline than male smokers. Hypertension, diabetes and number of ...

Strategic Update and New Path to Value CreationPalm Beach Gardens, FL, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: ...